A mother is suing Juul, claiming the e-cigarette maker's nicotine cartridges were a significant factor in causing the death of her 18-year-old son over a year ago, Bloomberg Law reports.
Why it matters: It's the first wrongful-death vaping suit against a major e-cigarette company, as the country's death toll from the illness reaches 26.
Voters want to hear more from the Democratic candidates about health care topics that they believe have been neglected during the debates, according to a new poll by the Kaiser Family Foundation.
If tonight’s Democratic debate is anything like the earlier ones, it will feature an extended back-and-forth about whether to eliminate private health insurance, and then move on from health care. But there’s a whole lot more that’s also worth asking about.
The big picture: We basically know what the candidates will say about the question of private insurance, because they’ve said it all before. So here are four other questions that might also help illuminate the choice voters face on such a deeply personal, wildly complex topic.
The Trump administration's health care agenda suffered 2 more setbacks in court on Friday.
Driving the news: A federal judge in New York blocked implementation of the administration's "public charge" rule, which would make it harder for immigrants to gain legal status if they're likely to rely on public programs — including Medicaid or subsidies through the Affordable Care Act.
Johnson & Johnson has spent $900 million on litigation in the first half of this year, and that tally is only going to swell.
The big picture: J&J is fighting thousands of legal battles over the safety of its prescription drugs and medical devices — chipping away at public trust in a health care company that has become a household name, and threatening to strip billions of dollars out of its coffers.
Although opioid prescriptions in the U.S. have fallen, opioid overdose deaths — 47,000 in 2018 — remain at historic levels. The continued spread of fentanyl and other illicitly manufactured synthetic opioids suggest the problem could still get worse.
The big picture: Inexpensive and widely available on the internet, fentanyl is attractive to dealers who make counterfeit prescription pills or mix it into heroin. Fentanyl, however, is extremely potent, leading more users to fatally overdose.
